Retinal implants have gained increasing interest since it was demonstrated in acute trials that completely blind subjects do have light perception upon electrical stimulation of the inner surface ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

A rare, progressive neurodegenerative disease associated with loss of macular photoreceptors in the retinas, MacTel type 2 ...

Vivani Medical, Inc. (NASDAQ:VANI) said it intends to spin off Cortigent, Inc., a division that develops brain implant ...

The implant was also shown to be safe and well ... Charles Wykoff, director of research at Retinal Consultants of Texas and an investigator in the Encelto clinical trials, said in Neurotech ...

The US Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular ...

In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...

Branded as Encelto, revakinagene taroretcel is a tiny implant containing lab-grown retinal cells. It is surgically placed in the eye, where it continuously delivers ciliary neurotrophic factor ...

The independent company will trade as Cortigent and advance brain implants to help people recover body functions such as ...

Cortigent will focus on neuromodulation devices while Vivani presses ahead with its weight loss drug implant. Vivani Medical ...